Enter assignee name

EPO Patents = 3

Forward Citations = 24

Loading Chart...

6 inventors (with patents filed for the assignee):

Martin P Maguire (8 out of 8 patents)

Harry Jefferson Leighton (7 out of 11 patents)

Elise Rioux (6 out of 10 patents)

4. Dominik Herbart (1 out of 3 patents)

5. Douglas Wight (1 out of 1 patent)

6. Francis Plat (1 out of 1 patent)

7. Martin P Maguire (0 patent)

9 patents: Sort by Forward Citations

1. 12257224 - Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker (2025-03-25),

2. 10117848 - Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof (2018-11-06),

3. 10010524 - Short acting phenylalkylamine calcium channel blockers and uses thereof (2018-07-03),

4. 10010523 - Short acting phenylalkylamine calcium channel blockers and uses thereof (2018-07-03),

5. 10010522 - Short acting phenylalkylamine calcium channel blockers and uses thereof (2018-07-03),

6. 9737503 - Short acting phenylalkylamine calcium channel blockers and uses thereof (2017-08-22),

7. 9463179 - Short acting phenylalkylamine calcium channel blockers and uses thereof (2016-10-11),

8. 9227918 - Short acting phenylalkylamine calcium channel blockers and uses thereof (2016-01-05),

9. 8501727 - Short acting benzothiazepine calcium channel blockers and uses thereof (2013-08-06),

Milestone Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for cardiovascular and central nervous system diseases. Their lead product candidate is etripamil, a novel calcium channel blocker being developed for the treatment of paroxysmal supraventricular tachycardia.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

9 Patents

#2 in Saint-Laurent, QC

#1,636 in Canada

Saint-Laurent, QC, Canada

Milestone Pharmaceuticals Inc.